Login / Signup
Free as a BRD4: Bromodomain Inhibition Ameliorates Disease Phenotypes in a Model of MECP2 Deficiency and Is a Potential Therapy for Rett Syndrome.
Kay-Marie Joan Lamar
Gemma Louise Carvill
Published in:
Epilepsy currents (2020)
Keyphrases
</>
mouse model
case report
risk assessment